4-Hydroxy-4-methyl-N-(4-(2-fluoroethoxy)-7-morpholinobenzo[d]thiazol-2-yl)piperidine-1-carboxamide

ID: ALA4760845

PubChem CID: 162658052

Max Phase: Preclinical

Molecular Formula: C20H27FN4O4S

Molecular Weight: 438.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(O)CCN(C(=O)Nc2nc3c(OCCF)ccc(N4CCOCC4)c3s2)CC1

Standard InChI:  InChI=1S/C20H27FN4O4S/c1-20(27)4-7-25(8-5-20)19(26)23-18-22-16-15(29-11-6-21)3-2-14(17(16)30-18)24-9-12-28-13-10-24/h2-3,27H,4-13H2,1H3,(H,22,23,26)

Standard InChI Key:  FKAMJDQVNRCUNU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   24.8407  -15.2472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8456  -14.4342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1352  -14.8379    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1494  -17.6769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1483  -18.4964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8563  -18.9054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8545  -17.2680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5632  -17.6733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5634  -18.4965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3464  -18.7506    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8301  -18.0845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3460  -17.4187    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.8516  -16.4510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5592  -16.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5583  -15.2269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8511  -14.8171    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1432  -15.2269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1425  -16.0465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8542  -19.7212    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6465  -18.0870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0572  -17.3805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8744  -17.3830    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6508  -16.6716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0612  -15.9607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6583  -15.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4278  -15.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8324  -16.6665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5609  -20.1316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2697  -19.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9763  -20.1352    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  1  0
  7 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  6 19  1  0
 11 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 23 27  1  0
 24 25  1  0
 25  1  1  0
  1 26  1  0
 26 27  1  0
 19 28  1  0
 28 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4760845

    ---

Associated Targets(Human)

ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.53Molecular Weight (Monoisotopic): 438.1737AlogP: 2.86#Rotatable Bonds: 5
Polar Surface Area: 87.16Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.96CX Basic pKa: 0.11CX LogP: 1.68CX LogD: 1.58
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.75Np Likeness Score: -1.49

References

1. Renk DR,Skraban M,Bier D,Schulze A,Wabbals E,Wedekind F,Neumaier F,Neumaier B,Holschbach M.  (2021)  Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A receptor ligands.,  214  [PMID:33548636] [10.1016/j.ejmech.2021.113214]

Source